Follow-Up Testing Schedule After Syphilis Treatment

Standard Follow-Up Protocol

The Centers for Disease Control and Prevention recommends that patients treated for primary and secondary syphilis should be monitored with clinical and serologic evaluation at 6 and 12 months after treatment 1, 2
For latent syphilis, follow-up should occur at 6, 12, and 24 months after treatment, as recommended by the Centers for Disease Control and Prevention 1
Sequential serologic tests should use the same testing method, preferably by the same laboratory, to ensure accurate comparison of results, according to the Centers for Disease Control and Prevention 1

HIV-infected patients require more frequent monitoring at 3, 6, 9, 12, and 24 months after therapy, as recommended by the Centers for Disease Control and Prevention 3, 4
A cerebrospinal fluid examination may be recommended 6 months after therapy for HIV-infected patients, although this is of unproven benefit, according to the Centers for Disease Control and Prevention 3

A fourfold decline in nontreponemal test titer within 6-12 months is considered evidence of adequate treatment response, as recommended by the Centers for Disease Control and Prevention 1
Treatment failure should be suspected if clinical signs or symptoms persist or recur, according to the Centers for Disease Control and Prevention 2
Treatment failure should also be suspected if there is a sustained fourfold increase in nontreponemal test titer, as recommended by the Centers for Disease Control and Prevention 2
Nontreponemal test titers should decline fourfold within 6 months for primary/secondary syphilis or 12-24 months for latent syphilis, according to the Centers for Disease Control and Prevention 2, 1

Some patients may remain "serofast" with persistent low-level positive titers despite adequate treatment, as noted by the Centers for Disease Control and Prevention 1
If titers remain serofast, patients should be reevaluated for HIV infection, according to the Centers for Disease Control and Prevention 2
For patients with persistent titers who cannot be ensured additional follow-up, re-treatment is recommended, as suggested by the Centers for Disease Control and Prevention 2
If re-treatment is necessary, most specialists recommend weekly injections of benzathine penicillin G 2.4 million units IM for 3 weeks, unless cerebrospinal fluid examination indicates neurosyphilis, according to the Centers for Disease Control and Prevention 2, 5

The Centers for Disease Control and Prevention advises against comparing titers between different test types as they are not directly comparable 1
The Centers for Disease Control and Prevention also advises against assuming that persistent low-titer reactivity necessarily indicates treatment failure or reinfection 1
Approximately 15-25% of patients treated during primary syphilis may revert to serologically nonreactive after 2-3 years, while others may remain serofast for life, as noted by the Centers for Disease Control and Prevention 1

The Centers for Disease Control and Prevention recommends monitoring late-latent syphilis at 6, 12, 18, and 24 months after treatment to ensure at least a fourfold decline in nontreponemal test titer 6, 7
By 18 months, most successfully treated patients with early syphilis will have achieved significant nontreponemal titer decline 6, 7
Approximately 15-20% of patients remain "serofast," meaning nontreponemal test titers remain reactive at low and unchanging titers, usually <1:8, for prolonged periods or even life 6, 7
A sustained fourfold increase in nontreponemal test titer compared to the lowest post-treatment titer may indicate treatment failure or reinfection 6, 7

HIV-infected patients require more frequent monitoring at 3-month intervals, rather than 6-month intervals 6, 7